Ted Okon Explains the Narrow SCOTUS Ruling on 340B Reimbursements
There's a lot of misinformation about this Supreme Court decision on Medicare reimbursement for 340B hospitals.
As Backlog of Delayed Cancer Screenings are Addressed, Inequities in Care Persist
When the COVID-19 pandemic forced patients with cancer to stay home and take extra precautions, it also forced thousands of others to delay routine screenings that would inform them of a potential cancer diagnosis.
Cancer organizations express mixed reactions to Enhancing Oncology Model
A new voluntary oncology payment model the Biden administration announced earlier this summer has been met with support, as well as concerns, from several cancer organizations.
Ted Okon Discusses the Impact of PBM Involvement in 340B
The involvement of pharmacy benefit managers (PBMs) in 340B is the “colliding of 2 worlds,” said Ted Okon, MBA, executive director, Community Oncology Alliance (COA).
CMS Announces Enhancing Oncology Model Successor to Oncology Care Model
Federal lawmakers are at the plate again, ready to take a swing at prescription drug prices.
Hematology-Oncology Associates of Central New York Lends Its Voice to Growing Chorus of Oncologists Opposing New York’s New Definition of the “Oncologic Protocol”
As previously reported, Frier Levitt filed suit against the New York Department of Health and the New York State Department of Education on behalf of an independent New York oncology practice in an effort to void the State’s new and legally unsupported definition of the “oncologic protocol”.
Scarborough-based New England Cancer Specialists names new CEO
New England Cancer Specialists, a Scarborough-based medical oncology practice, has named a health care executive with over 30 years’ experience as CEO.
Ted Okon: FTC Should Set Up Guardrails to Protect Americans From PBM Practices
I think it's really [ground]breaking to have the FTC look at PBMs and the abuses that PBMs basically foist on society.
Community Oncology Alliance Statement on Proposed 2023 Medicare Physician Fee Schedule
WASHINGTON, DC, UNITED STATES, July 8, 2022 /EINPresswire.com/ -- Statement from Ted Okon, Executive Director, COA The proposed Medicare Physician Fee Schedule for calendar year 2023 (CY2023) released by the Centers for Medicare & Medicaid Services (CMS) is yet another in a series of relentless and mindless payment cuts that the agency has made
Community Oncology Alliance Statement on Medicare Drug Pricing Negotiation in Reconciliation Bill
VIRGINIA BEACH, VIRGINIA, UNITED STATES, July 7, 2022 /EINPresswire.com/ -- The proposed Prescription Drug Pricing Reform provisions in the reconciliation bill that Senate Democrats are crafting implements the negotiation of drug prices in such a way that community oncology practices, as well as other specialty medical practices treating serious diseases, will face unbearable financial
